Cite
HARVARD Citation
Bol, K. et al. (n.d.). 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity. Journal for immunotherapy of cancer. p. A487. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bol, K. et al. (n.d.). 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity. Journal for immunotherapy of cancer. p. A487. [Online].